Navigation Links
Bayer CropScience Announces LibertyLink LinkUp Offer Increased for 2013 Season
Date:12/3/2012

Research Triangle Park, NC (PRWEB) December 03, 2012

Bayer CropScience announces the 2013 LibertyLink® LinkUp™ Offer, an important part of the Innovation Plus™ program. Growers who plant at least 150 acres* of LibertyLink soybeans, F iberMax® or Stoneville® LibertyLink cottonseed varieties, and/or InVigor® LibertyLink canola will be eligible for the following cash equivalent rebate:

  •     FiberMax and Stoneville LibertyLink cottonseed / $30 per unit
  •     LibertyLink soybean seed / $5 per unit
  •     InVigor LibertyLink canola seed / $30 per unit

“We are committed to providing valuable tools to growers that enhance their bottom line. This is a great time to try the most reliable weed managament solution available,” said Arlene Cotie, product manager for the LibertyLink trait. “High-yielding LibertyLink varieties and hybrids paired with Liberty herbicide provide a proven resistance management tool that fits any management plan.”

This program ensures that LibertyLink soybeans, FiberMax or Stoneville LibertyLink cottonseed varieties, or InVigor LibertyLink canola remain a viable and competitive alternative to other herbicide-tolerant technologies in the marketplace, according to Cotie.

LibertyLink System Shows Increased Value
Grower demand for the LibertyLink system has increased significantly in recent years and is expected to continue in 2013. As a result, Bayer CropScience has taken steps to help meet this growing need.

“Bayer CropScience encourages growers to work with their retailer to forecast Liberty herbicide needs when they book their LibertyLink soybeans, cotton or canola,” said Eric Peters, product manager for Liberty® herbicide. “This will help to better align distribution of Liberty herbicide to growers who have purchased LibertyLink crops.”

“A hotline has also been established at 1-800-432-9316 if growers would like to enter and/or confirm their Liberty herbicide forecast,” said Peters. Bayer CropScience encourages growers to focus their use of Liberty on LibertyLink crops to help ensure availability.

Seed orders for the 2013 growing season placed between Sept. 1, 2012, and Feb. 1, 2013, as well as previous purchases for the 2013 season, qualify for the incentive. For more information on the LinkUp Program, growers can contact their preferred seed seller or supplier. Additional program details are at http://www.InnovationPlusProgram.com.

*Based on seeding rates of 1 acre/unit of soybean seed, 5 acres/unit of cottonseed and 10 acres/unit canola seed.

###

Follow Bayer at @Bayer4CropsUS. Suggested Tweet:

About Bayer CropScience
Bayer is a global enterprise with core competencies in the fields of health care, agriculture and high-tech materials. Bayer CropScience, the subgroup of Bayer AG responsible for the agricultural business, has annual sales of EUR 7.255 billion (2011) and is one of the world’s leading innovative crop science companies in the areas of seeds, crop protection and non-agricultural pest control. The company offers an outstanding range of products including high value seeds, innovative crop protection solutions based on chemical and biological modes of action as well as an extensive service backup for modern, sustainable agriculture. In the area of non-agricultural applications, Bayer CropScience has a broad portfolio of products and services to control pests from home and garden to forestry applications. The company has a global workforce of 21,000 and is represented in more than 120 countries. This and further news is available at: press.bayercropscience.com.

Contact:
Bayer CropScience Media Hotline, 1-877-879-6162, or

Arlene Cotie
Bayer CropScience
Tel: (919) 549-2287
Email: arlene(dot)cotie(at)bayer(dot)com

Jayma Appleby
Rhea + Kaiser
Tel. (630) 955-2508
jappleby(at)rkconnect(dot)com

CR0912LBLINKA054V00R0
USA-BCS-2012-0492

Find more information at bayercropscience.us.

Forward-Looking Statements
This release may contain forward-looking statements based on current assumptions and forecasts made by Bayer Group or subgroup management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer’s public reports which are available on the Bayer website at bayer.com. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.

Read the full story at http://www.prweb.com/releases/BayerCropScience/LibertyLink/prweb10197659.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved  

Related biology technology :

1. QIAGEN and Bayer HealthCare Partner to Develop Companion Diagnostics to Guide Treatment Decisions for Targeted Cancer Therapies
2. Bayer Advanced(TM) Sets Sights on New Partnerships in 2013
3. Bayer HealthCares Cotavance® Drug Eluting Balloon With Paccocath® Technology Reduced Five-Year Target Lesion Revascularization Rates by 59 Percent in PAD Patients Compared to Those Treated With Uncoated Balloon
4. IntelliCell BioSciences Announces Research Agreement with the New Jersey Center for Biomaterials at Rutgers-The State University of New Jersey
5. Genomic Health Announces Presentation of Six Studies at the 2012 CTRC-AACR San Antonio Breast Cancer Symposium
6. Smith & Nephew Announces Agreement To Acquire Assets Of Healthpoint Biotherapeutics
7. Ampio Pharmaceuticals, Inc. (AMPE) announces appointment of Josh Disbrow as Chief Operating Officer effective December 15, 2012
8. Amarantus BioSciences Announces Positive Data for MANF in Delivery Diffusion Animal Model of Parkinsons Disease
9. BioRestorative Therapies Announces Launch of New Website
10. IntelliCell BioSciences Announces Michael Hershman Joins the IntelliCell BioSciences Board of Directors
11. Cardium Announces Patent Award For Rights To Cardiovascular Gene Therapy For The Treatment Of Heart Disease
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Bayer CropScience Announces LibertyLink LinkUp Offer Increased for 2013 Season
(Date:10/12/2017)... ... October 12, 2017 , ... ... launched Rosalind™, the first-ever genomics analysis platform specifically designed for life science ... in honor of pioneering researcher Rosalind Franklin, who made a major contribution ...
(Date:10/11/2017)... ... 11, 2017 , ... The CRISPR-Cas9 system has ... and avoiding the use of exogenous expression plasmids. The simplicity of programming this ... gain-of-function studies. , This complement to loss-of-function studies, such as with RNAi ...
(Date:10/11/2017)... ... , ... ComplianceOnline’s Medical Device Summit is back for its 4th year. The ... Francisco, CA. The Summit brings together current and former FDA office bearers, regulators, industry ... officials from around the world to address key issues in device compliance, quality and ...
(Date:10/11/2017)... INDIANAPOLIS , Oct. 11, 2017  VMS BioMarketing, a ... of a nationwide oncology Clinical Nurse Educator (CNE) network, which ... growing need for communication among health care professionals to enhance ... physicians, nurses, office staff, and other health care professionals to ... for breast cancer. ...
Breaking Biology Technology:
(Date:4/3/2017)... , April 3, 2017  Data captured ... engineering platform, detected a statistically significant association ... prior to treatment and objective response of ... potential to predict whether cancer patients will ... treatment, as well as to improve both pre-infusion ...
(Date:3/30/2017)... 2017 Trends, opportunities and forecast in this ... technology (fingerprint, AFIS, iris recognition, facial recognition, hand geometry, ... end use industry (government and law enforcement, commercial and ... and others), and by region ( North America ... Asia Pacific , and the Rest of the ...
(Date:3/27/2017)... CENTRE, N.Y. , March 27, 2017 /PRNewswire-USNewswire/ ... Healthcare Information and Management Systems Society (HIMSS) Analytics ... Outpatient EMR Adoption Model sm . In addition, ... 12% of U.S. hospitals using an electronic medical ... CHS for its high level of EMR usage ...
Breaking Biology News(10 mins):